pharmaphorum

NOVEMBER 17, 2022

As medical treatments become more complex, the role of the Medical Science Liaison (MSL) has never been more important. Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology.

Communication 114

Communication Pharmaceutical Companies Pharmaceutical Companies 114

Hospital Pharmacy Europe

DECEMBER 18, 2023

To this end, the Society of Geriatric Oncology and the French Society of Oncology Pharmacists have published a position paper to support this collaboration. Here, Chloé Herledan PharmD PhD, pharmacist, Clinical Oncology Pharmacy Unit, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France, shares an overview.

Chemotherapy 96

Chemotherapy Hospitals Labelling Communication 96

European Pharmaceutical Review

DECEMBER 12, 2023

Additionally, Morel shares highlights and key clinical data from Innate Pharma’s pipeline and as well as his predictions on where the sector is headed, meanwhile considering the impact of accelerating technological innovations. Innate Pharma is an international clinical-stage biotechnology oncology company based in France.

Immunization 113

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 113

pharmaphorum

JULY 8, 2021

GlaxoSmithKline’s head of oncology Axel Hoos has resigned from the company, and will take up a new role as chief executive of US biotech Scorpion Therapeutics. . billion acquisition of Tesaro, which added PARP inhibitor Zejula (niraparib) and a pipeline of other oncology candidates.

Compounding 105

Compounding 105

STAT

JULY 3, 2023

There was also a positive early trend on overall survival, with Susan Galbraith , AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients. But investors had been hoping for a clearer signal of benefit.

Chemotherapy 96

Chemotherapy 96

Hospital Pharmacy Europe

OCTOBER 12, 2023

The launch of a systemic anti-cancer therapies (SACT) passport allowing pharmacy staff who have undertaken oncology pharmacy training to move between organisations in the UK without the need for retraining and validation has been announced by the British Oncology Pharmacy Association (BOPA).

Chemotherapy 52

Chemotherapy Hospitals 52

European Pharmaceutical Review

NOVEMBER 7, 2023

Positive results for a combination treatment using the first Fc-silent investigational monoclonal antibody in pivotal clinical trials that is designed to block and bind to the T-cell immunoreceptor with Ig and ITIM domains (TIGIT), have been announced. The treatment is being evaluated in patients with upper GI adenocarcinomas.

Chemotherapy 99

Chemotherapy 99

European Pharmaceutical Review

NOVEMBER 16, 2023

In the past couple of months, BeiGene has experienced regulatory progress for two of its oncology assets in clinical development. According to Data Bridge Market Research, the haematology /oncology market will value $14.83 According to Data Bridge Market Research, the haematology /oncology market will value $14.83

Immunization 52

Immunization 52

Hospital Pharmacy Europe

AUGUST 17, 2023

Here, Tiene Bauters PharmD PhD, Pharmacy, Department of Pediatric Hemato-Oncology & Stem Cell Transplantation at Ghent University Hospital in Belgium, shares an overview of the involvement of the pharmacist in CAR T-cell services. The different roles and steps to be undertaken by hospital pharmacists are clearly described.

Hospitals 98

Hospitals Documentation Chemotherapy Pharmaceutical Companies 98

European Pharmaceutical Review

JUNE 27, 2023

In April 2023, MaaT Pharma announced that the FDA cleared the Investigational New Drug (IND) application to initiate in the US Phase III pivotal clinical trial evaluating MaaT013 for the treatment of acute graft vs host disease. What are the most promising microbiome therapeutics in clinical development?

Chemotherapy 103

Chemotherapy Immunization FDA Vaccines 103

Board Vitals - Pharmacist

JANUARY 11, 2024

Since Christie’s or Franklin’s or Pemberton’s eras, the role of the pharmacist has changed. Pharmaceutical industry: Pharmacists may design or conduct clinical drug trials and help to develop new drugs. According to the U.S. Licensing boards for these specialties vary. Or recognize them on social media by using #NationalPharmacistDay.

Retail Drug Stores 98

Retail Drug Stores Hospitals Insurance Patient Care 98

pharmaphorum

JUNE 1, 2022

For the first time since 2019, the American Society of Clinical Oncology (ASCO) annual meeting will be an in-person conference. We’re excited to re-connect with fellow oncology and clinical care professionals from across the globe to learn from one another and discuss key advances in cancer care and research.

Hospitals 58

Hospitals 58

pharmaphorum

MARCH 23, 2022

Merck & Co’s chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement from the company to take up a new role alongside his former colleague Roger Perlmutter at biotech Eikon Therapeutics. billion last year.

Vaccines 98

Vaccines FDA 98

European Pharmaceutical Review

FEBRUARY 6, 2023

PKC theta plays a critical role in controlling T cell function and is a key driver of several highly prevalent autoimmune diseases. ” Clinical success begins early for small molecule drugs… The need for sustained, high levels of target inhibition was required to drive efficacy.

Compounding 91

Compounding Immunization 91

Pharmaceutical Technology

MAY 30, 2023

Genmab AS’s epcoritamab presents as the top European drug launch and only oncological therapy. Moreover, the top three drug launches are set for first release within this region, further underscoring the prominent role of the US market and its profound influence on the pharmaceutical sector. Similarly, Almirall S.A.,

Vaccines 105

Vaccines 105

STAT

JUNE 7, 2023

What did we learn from this year’s annual meeting of the American Society of Clinical Oncology? STAT had the story of Susan Galbraith , AstraZeneca’s head of cancer research, and her role in making that happen. And that was the result of a decade-and-a-half of work by researchers at the drug’s maker.

Patient Care 92

Patient Care 92

European Pharmaceutical Review

APRIL 12, 2023

In November 2022, the Medicines and Healthcare products Regulatory Agency (MHRA) Innovation Passport was awarded to Boehringer Ingelheim’s investigational BI 907828 in de-differentiated liposarcoma (DDLPS), a rare and aggressive oncology indication for which there has been no new first-line treatment in over forty years.

Immunization 90

Immunization 90

European Pharmaceutical Review

JANUARY 9, 2024

TALZENNA the first and only PARP inhibitor licensed in the EU for use with XTANDI for patients with mCRPC, with or without gene mutations” The treatment is indicated for adults with metastatic castration-resistant prostate cancer (mCRPC) in individuals where chemotherapy is not clinically indicated.

Chemotherapy 90

Chemotherapy FDA 90

pharmaphorum

FEBRUARY 24, 2022

This enabled rapid recruitment to multiple COVID-19 clinical trials throughout England/UK. . Can data help us to identify where there is high clinical need and/or research low engagement? Stephen Lock is head of business intelligence, NIHR Clinical Research Network. Ed Merivale is therapy relationship manager, oncology at NIHR.

Hospitals 104

Hospitals 104

European Pharmaceutical Review

APRIL 3, 2023

These results have led to a major amendment in a European Phase III paediatric clinical trial. The oncology treatment showed clinical activity across patients of all ages with the three neuroblastoma-specific hotspot ALK mutations. In 2008, the ALK gene was found to hold a key role in the disease.

Chemotherapy 82

Chemotherapy Hospitals FDA 82

pharmaphorum

OCTOBER 17, 2022

Their success led to the discovery of an entirely new principle for cancer therapy – the field of immuno-oncology – one that is now a mainstay of cancer treatment, changing the way these diseases can be managed. Marie-Louise Fjällskog has over 30 years of experience in clinical oncology, translational research, and drug development.

Immunization 114

Immunization 114

IDStewardship

AUGUST 1, 2023

I had the good fortune of connecting with Dr. Emre Kara at the European Congress on Clinical Microbiology and Infectious Diseases in 2022, who lives and works in Turkey as a pharmacist practicing in the area of antimicrobial stewardship. Clinical pharmacy in Turkey is still developing. I graduated from Pharmacy in June 2014.

Hospitals 212

Hospitals Community Pharmacies Dosage Communication 212

pharmaphorum

JANUARY 7, 2022

As chief medical officer, head of global medical affairs, patient safety and patient affairs – putting patient interests first is central to my role and values. Quality of life-specific endpoints need to be a permanent component of future clinical trial protocols. I often ask myself where the next leap in patient care will come from.

Patient Care 105

Patient Care 105

Hospital Pharmacy Europe

DECEMBER 13, 2022

Apart from being a heterogenous population, paediatrics embraces a constellation of different medical disciplines, many in constant evolution in terms of drug development and drug research (such as in paediatric oncology, where numerous clinical trials with new drugs and cellular therapies are ongoing).

Hospitals 105

Hospitals Compounding 105

pharmaphorum

SEPTEMBER 8, 2021

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology. The post Biotech Insight podcast: Overcoming planning challenges in oncology appeared first on.

52

52

European Pharmaceutical Review

DECEMBER 30, 2023

Oncology continued to dominate the dealmaking in terms of therapeutic area, most notably antibody-drug conjugates (ADCs), which were the key asset in three major deals,” he adds. Strategic partnerships and alliances will continue to play critical roles in early-stage R&D.” What modalities will dominate biopharma dealmaking in 2024?

105

105

pharmaphorum

FEBRUARY 21, 2022

The clinical research industry has long struggled with participant diversity. One study found that only 5% of Black or Asian United Kingdom residents had ever participated in a clinical trial. With many patients unable to travel, clinical trial sites initiated more remote, flexible, and hybrid trials than ever before.

Vaccines 110

Vaccines FDA Hospitals 110

pharmaphorum

JULY 23, 2021

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down. As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper.

52

52

pharmaphorum

JUNE 8, 2021

Speaking to us after his appearance on the Withers podcast Talking Success , Mei says he founded Antengene – after leading oncology drug development at J&J, Novartis and Celgene– to address this need for innovative drugs with best-in-class and/or first-in-class potential targeting medical needs specific to APAC. Unmet needs in cancer.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

The Checkup by Singlecare

FEBRUARY 1, 2024

Estrogen is a key female hormone with a crucial role in sexual and reproductive health. Estrogen plays roles in cholesterol, blood sugar levels, bone and muscle mass, and brain function. Foods not high in estrogen Many factors play a role in maintaining healthy hormone levels beyond diet, including age and other medical conditions.

Mayo Clinic 95

Mayo Clinic Compounding FDA 95

pharmaphorum

APRIL 11, 2022

As an oncology trained medical doctor who practiced in the UK NHS for 10 years, I have seen the benefits first-hand, as patients live longer lives, free from symptoms, and are able to return to work. The role of innovation in value-based healthcare. And it all fuels the debate: are medicines a cost or an investment?

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 114

pharmaphorum

APRIL 19, 2022

It has long been understood that the Hippo pathway plays a critical role in the development of a wide range of diseases. Together, we will unite to learn, debate, and discuss; leverage the therapeutic opportunity of this pathway; and critically address the huge unmet clinical need. Download the full event guide here.

52

52

pharmaphorum

NOVEMBER 15, 2022

Lantheus’ pipeline-building drive in radiopharma has continued with a $260 million upfront deal to license rights to two oncology candidates from POINT Biopharma. The post Lantheus on POINT in radio-oncology with $2bn licensing deal appeared first on.

Chemotherapy 52

Chemotherapy FDA 52

European Pharmaceutical Review

NOVEMBER 4, 2022

Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour The importance of taxanes in oncology. Taxanes have played an important role in anticancer treatment for several decades. tumour effects.

Chemotherapy 88

Chemotherapy FDA Hospitals Packaging 88

pharmaphorum

JANUARY 17, 2023

and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists detecting lung cancer in chest X-rays. The study will look at CT scans and clinical data from 200 patients with confirmed lung cancer who are on systematic therapy, and compare automated assessment using e-ACT to radiologist review.

109

109

Pharmaceutical Technology

JUNE 10, 2023

Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Metastatic Lung Cancer. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It is formulated as tablets for oral route of administration.

Chemotherapy 40

Chemotherapy 40

Pharmaceutical Technology

JUNE 10, 2023

Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Metastatic Lung Cancer. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It is formulated as tablets for oral route of administration.

Chemotherapy 40

Chemotherapy 40